Literature DB >> 3871738

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data.

P Sipponen, M Kekki, J Haapakoski, T Ihamäki, M Siurala.   

Abstract

Relative risk (RR) and cumulative risk of gastric cancer (GCA) were calculated for different grades of atrophic gastritis (AG) of the antrum and body. Cross-sectional data on the occurrence of AG in a representative population sample (371 subjects), and Finnish Cancer Registry data on GCA were used in the calculations. The RR was increased significantly in severe AG of the antrum and the body (18.1 and 4.6 times, respectively), but not significantly in the less severe grades of AG. As a risk factor, severe antral and body gastritis were independent of each other. The cumulative risk, i.e., the probability of contracting GCA within the following 10 years in age groups 50-54 . . . 70-74 years was calculated to vary from 2.3% to 9.3% and from 8.7% to 31.9% in severe antral AG and from 0.9% to 4.5% and from 3.6% to 16.6% in severe body AG in males and females, respectively.

Entities:  

Mesh:

Year:  1985        PMID: 3871738     DOI: 10.1002/ijc.2910350206

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  81 in total

1.  Helicobacter pylori infection and chronic gastritis in gastric cancer.

Authors:  P Sipponen; T U Kosunen; J Valle; M Riihelä; K Seppälä
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.

Authors:  Katsunori Iijima; Yasuhiko Abe; Ryosuke Kikuchi; Tomoyuki Koike; Shuichi Ohara; Pentti Sipponen; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

3.  Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.

Authors:  Arto Kokkola; Johanna Louhimo; Pauli Puolakkainen; Henrik Alfthan; Caj Haglund; Hilpi Rautelin
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

4.  Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Authors:  E J Kuipers; G F Nelis; E C Klinkenberg-Knol; P Snel; D Goldfain; J J Kolkman; H P M Festen; J Dent; P Zeitoun; N Havu; M Lamm; A Walan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  Gastric pouch adenocarcinoma and tubular adenoma of the pylorus: a field effect of dysplasia following bariatric surgery.

Authors:  I Chebib; P L Beck; N G Church; S A C Medlicott
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

6.  Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells.

Authors:  Marju Gruno; Nadezhda Peet; Andres Tein; Riina Salupere; Meeli Sirotkina; Julio Valle; Ants Peetsalu; Enn K Seppet
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

Review 7.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

8.  Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

Authors:  Yoshihisa Urita; Kazuo Hike; Naotaka Torii; Yoshinori Kikuchi; Eiko Kanda; Masahiko Sasajima; Kazumasa Miki
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

9.  Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

10.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.